NCT01908530View on ClinicalTrials.gov

Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2018

Conditions
Diabetes Mellitus
Interventions
DEVICE

Microprobe glucose sensor

Assessment of safety and accuracy of a novel continuous glucose monitor based on microprobe technology.

Trial Locations (1)

W2 1PG

Imperial College London, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT01908530 - Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes | Biotech Hunter | Biotech Hunter